EUVIMEDEUVIMED entdecken
Crossref

Population‐based prevalence of epilepsy in Uganda: A nationwide cross‐sectional survey

Angelina Kakooza-Mwesige iD, Anthony T Fuller iD, Paula N Njeru iD, Fredrick E Makumbi iD, Christine Muhumuza iD, Noeline Nakasujja iD, Mark Kaddumukasa iD, Martin N Kaddumukasa iD, Juliet Nakku iD, Michael M Haglund iD, Brad J Kolls iD, Taimur Hassan iD und 2 weitere

Epilepsia · 2025

DOI: 10.1111/epi.18533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Angelina Kakooza-Mwesige und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Epilepsy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: NICHD NIH HHS, King Baudouin Foundation United States, UCB Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Establishing the prevalence of epilepsy in Uganda is crucial to inform interventions and public policy. We conducted a nationwide survey to determine epilepsy prevalence.

Methods

From January 2019 to July 2022, a door‐to‐door survey was conducted across all four regions of Uganda, targeting a nationally representative sample of households. Trained field teams identified and interviewed heads of households to obtain demographic information, and three household members were randomly selected for epilepsy screening. A two‐part survey, adapted from a validated standardized epilepsy questionnaire in low‐ and middle‐income countries, was used for screening. To ensure the accuracy of the prevalence estimates, a subset of screened individuals underwent clinical validation by a qualified neurologist. Epilepsy was defined per the International League Against Epilepsy (ILAE) criteria. We employed Monte Carlo simulation to extrapolate prevalence estimates.

Results

We identified and screened 35 055 participants (53.5% female). The ages ranged from 1 month to 108 years, with a mean age of 20.7 years. The overall crude epilepsy prevalence was estimated at 16.9 per 1000 persons, with an age‐ and sex‐adjusted prevalence rate of 17.8 per 1000. The differences in sex‐specific prevalence rates were not statistically significant. The highest age‐specific prevalence rate of 25.0 per 1000 occurred in the 20‐ to 39 ‐year age group. There was a substantial variation in epilepsy prevalence across the various regions, with the highest prevalence recorded in the eastern region and the lowest in the northern region. Significance Our study underscores the high epilepsy burden in Uganda, particularly among adults, and reveals age, gender, and geographical variation likely arising from disparities in the underlying determinants. Identification of these factors is crucial for addressing treatment gaps and reducing epilepsy prevalence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyHumansUgandaFemaleMaleCross-Sectional StudiesAdultPrevalenceAdolescentChildMiddle AgedChild, PreschoolYoung AdultInfantAgedAged, 80 and overSurveys and Questionnaires

Stichwörter der Autor:innen

Ugandaepilepsypopulation‐basedprevalence

Autor:innen und Institutionen

  • Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda.
  • Pediatric Neurology Unit, Department of Paediatrics and Child Health, Mulago National Referral Hospital, Kampala, Uganda.
  • Duke Division of Global Neurosurgery and Neurology, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Duke Global Health Institute, Durham, North Carolina, USA.
  • Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Epidemiology and Biostatistics, Makerere University School of Public Health, Kampala, Uganda.

ORCID-Profile: Angelina Kakooza-Mwesige, Anthony T Fuller, Paula N Njeru, Fredrick E Makumbi, Christine Muhumuza, Noeline Nakasujja, Mark Kaddumukasa, Martin N Kaddumukasa, Juliet Nakku, Michael M Haglund, Brad J Kolls, Taimur Hassan, Dirk E Teuwen, Deborah C Koltai

Förderung

  • NICHD NIH HHS
  • King Baudouin Foundation United States
  • UCB Pharma

Zitieren

APA

Kakooza-Mwesige, A., Fuller, A. T., Njeru, P. N., Makumbi, F. E., Muhumuza, C., Nakasujja, N., Kaddumukasa, M., Kaddumukasa, M. N., Nakku, J., Haglund, M. M., Kolls, B. J., Hassan, T., Teuwen, D. E., & Koltai, D. C. (2025). Population‐based prevalence of epilepsy in Uganda: A nationwide cross‐sectional survey. Epilepsia. https://doi.org/10.1111/epi.18533

Vancouver

Kakooza-Mwesige A, Fuller AT, Njeru PN, Makumbi FE, Muhumuza C, Nakasujja N, et al. Population‐based prevalence of epilepsy in Uganda: A nationwide cross‐sectional survey. Epilepsia. 2025. doi:10.1111/epi.18533

BibTeX
@article{KakoozaMwesige2025,
  author = {Kakooza-Mwesige, Angelina and Fuller, Anthony T and Njeru, Paula N and Makumbi, Fredrick E and Muhumuza, Christine and Nakasujja, Noeline and Kaddumukasa, Mark and Kaddumukasa, Martin N and Nakku, Juliet and Haglund, Michael M and Kolls, Brad J and Hassan, Taimur and Teuwen, Dirk E and Koltai, Deborah C},
  title = {Population‐based prevalence of epilepsy in Uganda: A nationwide cross‐sectional survey},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18533}
}
Kostenlos starten →